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Saudi ArabiaAbstract Background: Good medication labeling practices are imperative to ensure safe medica-
tion use. Non-adherence to labeling protocols is reported as one major source of medication errors.
Objective: This study was intended to evaluate and compare adherence to labeling guidelines for
dispensed medications among the hospitals of the ﬁve different health sectors in the city of Riyadh,
Saudi Arabia.
Methods: A descriptive, cross-sectional analysis was conducted among 14 public hospitals in the
city of Riyadh, Saudi Arabia. Labeling guidelines issued by the Institute for Safe Medication Prac-
tices were used as a standard assessment tool. A total of 218 medication labels were collected and
evaluated for labeling adequacy. Descriptive statistics were used to elaborate the study ﬁndings. All
analyses were performed with Microsoft Access.
Results: The study showed a substantial rate of adherence to the labeling guidelines. In terms of
the established criteria, community and mail orders were reported to adhere strongly (90.5%),
whereas injectables adhered least to the labeling guidelines. The labeling format, contents of the
label, instructions on the labels, abbreviations used on the labels and drug names were also consis-
tent with the guidelines (80.0%, 84.0%, 88.0%, 97.7% and 85.5%, respectively). Organizations
346 S. Alkhani et al.belonging to the public sector reported a higher level of adherence (P80.0%) than the level found
for private hospitals (70.0%).
Conclusion: In Riyadh hospitals, medication labeling following the guidelines issued by the Insti-
tute for Safe Medication Practices, is well accepted and rationally practiced. However, a nationwide
study is recommended to evaluate if the guidelines are followed throughout Saudi Arabia.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The labeling of medications encompasses the provision of
information and instructions to ensure the safe and effective
use of the products by patients. The labels of dispensed medi-
cations represent one of the most important sources of infor-
mation available to patients (Neoh et al., 2009).
Legitimately, labeling information includes but is not limited
to the following categories: patient identiﬁcation, medication
name, dosage, frequency, route of administration, production
and expiration date and some medication storage requirements
(Brown-Brumﬁeld and Deleon, 2010). In contrast, medication
labeling in actual practice is almost always inconsistent,
incomplete or difﬁcult for patients to understand (Shrank
et al., 2007; Orser, 2000). This vague information causes med-
ication errors and produces very large economic and societal
losses (Aspden, 2007; Bootman et al., 2006).
Within this context, The Joint Commission, an organiza-
tion that accredits health care organizations in the United
States, described communication error as the cause of 60–
70% of preventable hospital deaths (Murphy and Dunn,
2010). Despite the ongoing efforts by international safety orga-
nizations (JCAHO, 2007), medication errors associated with
labeling and packaging are frequently reported (Cohen,
2007). Therefore, based on the scrutiny of actual medication
errors reported and a review of pharmacy-generated labels
produced by a number of systems, the Institute for Safe Med-
ication Practices (ISMP), an organization that educates the
health care community and consumers about safe medication
practices, released its ‘‘Designing a medication label for use
in the acute care and community pharmacy settings’’ guide-
lines in 2010 (ISMP, 2010). These guidelines provide detailed
information on labeling requirements for oral liquid, oral so-
lid, injectables, intravenous piggyback, and community and
mail-order pharmacy prescription packages (ISMP, 2010).
The aim of these guidelines is to promote rational labeling
standards, thus preventing medication errors. However, The
Joint Commission, The Joint Commission International and
ISMP are organizations in the United States and complying
with their guidelines is voluntary.
Concern may also focus on labeling practices in Saudi Ara-
bia, but less is known about this issue. To the best of our
knowledge and judging from the results of an extensive litera-
ture review, adherence to ISMP labeling guidelines has not yet
been investigated in Saudi Arabia. For this reason, there are
inadequate data on the impact of current labeling practices
on health professionals and use of medications by patients.
Furthermore, compliance with labeling guidelines has not been
compared among different health care sectors. A pilot study
was conducted in an effort to expand our current knowledge
on compliance by health care professionals with the current
labeling guidelines. The study aimed to evaluate adherenceto ISMP labeling guidelines and to compare the level of adher-
ence among different health care sectors in the city of Riyadh,
Kingdom of Saudi Arabia.2. Methods
The study was designed as a cross-sectional comparative anal-
ysis. The study was conducted in Riyadh, the capital of Saudi
Arabia. The total number of hospitals in Riyadh is forty-ﬁve as
per the 2012, Ministry of Health in Saudi Arabia census. From
these hospitals, fourteen (30% of the total number of hospi-
tals) from ﬁve different health sectors (Ministry of Health Sec-
tor, Military Sector, Referral Sector, Teaching Hospitals
Sector and Private Sector) were targeted for data collection.
Approval to conduct the study was obtained from the Medica-
tion Safety Research Chair Research Committee at King Saud
University. No patient-related information was collected to
maintain conﬁdentiality.
The ISMP guidelines for medication label design were used
to design a data collection tool. The guidelines were divided
into ﬁve major sections (label format, label content, label expli-
cit instructions, drug name and abbreviation section). Five dif-
ferent types of labels were included in the study: community
and mail order, intravenous piggyback, oral liquids, oral solids
and injectable syringes. The ﬁrst drafts of the collection tool
were reviewed by an ISMP representative. Few modiﬁcations
were needed, and the representative’s comments and guidelines
were considered in ﬁnalizing the data collection checklists.
A suitable sampling technique was used for data collection.
This established technique was to retrieve at least one label of
each category from each individual hospital. The sampling dis-
tribution is shown in (Table 1). The study was conducted from
October 2010 to December 10, 2010. A total of 208 medication
labels were collected. The data were entered and summarized
with Microsoft Access.
3. Results
Two hundred and eight labels were collected from 14 hospitals,
as shown in Table 1. The majority of the labels were collected
from referral hospitals (n= 84, 44.0%), followed by teaching
hospitals (n= 56, 27%), private hospitals (n= 25, 12%), mil-
itary services hospitals (n= 23, 11%) and Ministry of Health
(MOH) hospitals (n= 20, 10%).
3.1. Adherence rates
The overall adherence rates to the guidelines for community
and mail order, oral solids, intravenous piggyback, oral liquid
and injectable medication labels were 90.5%, 88.0%, 85.8%,
83.74%, and 81.0%, respectively. In addition, the rates of
Table 1 Number of labels per hospital.
Label type Hospitals Total
MOH* (N= 5) Military (N= 2) Referral (N= 5) Teaching (N= 4) Private (N= 4)
Community and mail orders 6 8 24 15 10 63
Oral solids 4 6 20 12 4 46
Oral liquids 3 1 19 9 1 33
Injectables 4 2 13 13 1 33
Intravenous Piggyback 3 6 8 7 9 33
Total 20 23 84 56 25 208
* Ministry of Health.
Table 2 ISMP label adherence rates.
Label Label
format (%)
Label contents
(%)
Explicit instruction
(%)
Abbreviations
(%)
Drug name
(%)
Total adherence
(%)
Injectables 79.0 72.2 NA 96.4 76.4 81.0
Oral solids 77.1 86.8 90.2 98.5 87.25 88.0
Oral Liquids 79.3 83.6 84.7 98.6 72.5 83.7
Community and mail orders 87.6 92.5 92.2 99.6 80.7 90.5
Intravenous piggyback 76.5 88.0 84.7 95.8 84.0 85.8
NA; Not applicable
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ation, and drug name sections were 80.0%, 84.0%, 88.0%,
97.7%, and 85.8%, respectively, as shown in (Table 2).
Fig. 1 shows the overall level of adherence to all the ele-
ments in the guidelines among the ﬁve health sectors. Military
service hospitals had the highest adherence level (90.1%), fol-
lowed by MOH hospitals (89.7%), referral (88.2%) and teach-
ing (79.8%). Private hospitals reported the lowest adherence
level (70.0%).
The lower adherence levels found in teaching and private
hospitals can be explained by the low adherence level shown
by these hospitals in the category of explicit instructions on
medication labels, as shown in Table 3.Figure 1 Classiﬁcation of hospitals in t4. Discussion
Adherence to the label design guidelines for medications used
in hospitals is crucial to ensure the safe use of medications. The
safety recommendations and initiatives developed by several
organizations are related directly or indirectly to the medica-
tion labels used in hospitals. For example, The Joint Commis-
sion International-Patient Safety Goals emphasizes the use of
proper patient identiﬁcation throughout the process of medica-
tion use to avoid the incorrect administration of medication to
patients, and this body also emphasizes the use of two patient
identiﬁers (JCIS, 2012). This study showed that the required
patient identiﬁcation available on the medication labelerms of medication label adherence.
Table 3 Medication labels and hospitals.
Hospital & label type Label format Label contents Explicit instructions Abbreviations Drug name
Ministry of Health
Intravenous piggyback 91.6 85.7 100 100 79.2
Injectables 83.0 80.0 NA 92.5 77.4
Oral solids 91.7 93.7 100 100 78.4
Oral liquids 93.3 91.0 100 100 91.0
Community and mail orders 93.3 91.0 100 100 76.0
Total 90.5 88.2 100 98.5 80.4
Military service hospitals
Intravenous piggyback 100 95.2 94.4 100 98.0
Injectables 87.6 73.3 NA 100 85.4
Oral solids 100 90.0 100 100 91.0
Oral liquids 72.0 100 100 100 80.0
Community and mail orders 72.0 82.0 100 100 70.0
Total 94.4 88.1 98.6 100 84.8
Referral hospitals
Intravenous piggyback 87.5 89.6 86.6 97.5 85.6
Injectables 77.8 90.0 NA 97.0 83.0
Oral solids 73.7 88.2 100 95.5 81.0
Oral liquids 84.0 89.0 97.4 100 77.4
Community and mail orders 82.3 89.0 97.4 100 77.4
Total 81.6 89.1 95.3 98.0 80.8
Teaching hospitals
Intravenous piggyback 83.3 94.0 69.4 87.5 74.0
Injectables 90.5 83.0 NA 95.0 84.0
Oral solids 71.8 88.1 38.5 100 75.5
Oral liquids 76.4 84. 61.1 100 65.5
Community and mail orders 80.3 87.0 61.1 100 71.1
Total 80.4 87.2 57.5 96.5 74.0
Private hospitals
Intravenous piggyback 87.5 89.3 83.3 100 90.6
Injectables 96.3 72.2 NA 99.0 76.4
Oral solids 100 20.0 0.0 100 72.7
Oral liquids 77.8 23.7 50.0 100 50.0
Community and mail orders 77.8 27.3 50.0 100 50.0
Total 87.9 46.5 45.8 99.8 68.0
NA; Not applicable
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tion. In the category of label content, the availability of a sec-
ond patient identiﬁer varies from 72% for injectable
medications to 93% for community and mail-order. The label
content for the patient identiﬁcation section needs to be re-
viewed for better adherence with the safety requirement.
The proper use of technology throughout the medication
use process was shown to possibly improve medication safety
and minimize medication errors (Kuiper et al., 2007; Poon
et al., 2006). This approach could be pursued and evaluated
through the availability of barcodes on medication labels to
facilitate barcode scanning of the medication before dispensing
and administration. The safe use of medications would be im-
proved signiﬁcantly by the inclusion of barcode information
(Poon et al., 2006). This topic was evaluated under the cate-
gory of label content, and it represents a potential area for
improvement.
In contrast, the hospitals generally showed good adherence
to the proper use of medication abbreviations. The adherence
rate varied from 96% to 100%. This result indicated no use or
a minimal use of dangerous or prohibited abbreviations.In addition, confusing drug names or ‘‘look-alike, sound-
alike’’ medication names are becoming a major safety concern
throughout the health care sector worldwide (WHO, 2007).
The appropriate display of medication names was evaluated
during the survey. This category includes the availability of
the generic medication name on the label, the use of an appro-
priate font and the use of ‘‘tall-man’’ letters if indicated. The
adherence rate in this category varied from 72% to 87%. This
result indicates that extra effort is needed to ensure the safer
display of medication names on the labels. This approach will
help to minimize errors resulting from the misinterpretation of
medication names by the patients or the health care providers.
Our study has several limitations. Certain hospitals were
not willing to share their labels. A smaller sample size resulted
from this limitation. In addition, the medications used at sev-
eral MOH hospitals had no labels, or the labels were available
but were not in use.
The current study focused on hospitals and the quality of
label information in community pharmacy is unknown. Future
studies need to investigate the label information in community
pharmacies. In Saudi Arabia, no speciﬁc regulations by the
Current practices for labeling medications in hospitals in Riyadh, Saudi Arabia 349Ministry of Health or other authority require certain informa-
tion to be on the label for medications dispensed by pharma-
cist in the hospital or community. Having national
regulations that ask for minimal medication label information
is an essential step to improve the safety of medications dis-
pensed in the hospital or community pharmacy.
In conclusion, this is the ﬁrst study to investigate hospitals’
adherence to ISMP design guidelines for medication labels in
Saudi Arabia. Our results suggest that in terms of the ISMP
guidelines, adherence to the medication labeling system is well
accepted by the hospitals in Riyadh. Broader studies are
needed to ascertain the status of adherence to the ISMP guide-
lines in the remainder of Saudi Arabia. The national and gov-
ernmental health care regulatory organizations need to play a
strong and leading role in promoting safe medication practices
and ensuring the utilization of well-designed medication labels
as applicable.
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